Shomari Ruffin, MD
Sports Medicine · Carrollton, GANPI 1114185840
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Smith+Nephew at 34.4% of the total. Reporting peaked in 2020 at $3,084 and has fallen 88.6% since, to $352 in 2025.
Across 123 payments — averaging $72.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Orthopedic Sciences, Inc.$2K
- Arthrex$1K
- FX Shoulder Solutions, Inc$1K
- Amgen$797
- Pacira Therapeutics, Inc.$283
- plus $658 from 13 others
What the payments were for
- Travel & lodging$4,77254%
- Food & beverage$2,93933%
- Education$1,20013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 17 | $3,064 |
| Orthopedic Sciences, Inc. | 1 | $1,515 |
| Arthrex | 3 | $1,364 |
| FX Shoulder Solutions, Inc | 1 | $1,231 |
| Amgen | 66 | $797 |
| Pacira Therapeutics, Inc. | 11 | $283 |
| Convatec Inc. | 2 | $167 |
| Johnson & Johnson | 6 | $161 |
| ERMI LLC | 3 | $67 |
| Stryker | 2 | $64 |
| Electronic Waveform Lab, Inc. | 2 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Vertex | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Orthogenrx Inc. | 1 | $15 |
| Acumed LLC | 1 | $14 |
| Heraeus Medical, LLC. | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,912 in reported general payments places this provider in the 70th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 22 | $47 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Carrollton
- Robert O'ConnellCarrollton$69K
- Kevin CharronCarrollton$33K
- John XerogeanesAtlanta$4M
- Joseph BurnsAlpharetta$376K
- Sameh LabibBrookhaven$280K
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Elan GolanSnellville$57K
- Taylor PolanderJesup$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.